Matthew Bardin
Chief Tech/Sci/R&D Officer at Romark, L.C.
Profile
Matthew Bardin is currently the VP-Medical Affairs, Research & Development at Romark, L.C.
Prior to this, he was the Senior Vice President-Operations at NeuroBo Pharmaceuticals, Inc. from 2022 to 2023.
He holds a doctorate degree from Mcwhorter School of Pharmacy.
Matthew Bardin active positions
Companies | Position | Start |
---|---|---|
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Chief Tech/Sci/R&D Officer | 2022-05-05 |
Former positions of Matthew Bardin
Companies | Position | End |
---|---|---|
NEUROBO PHARMACEUTICALS, INC. | Chief Operating Officer | 2023-01-31 |
Training of Matthew Bardin
Mcwhorter School of Pharmacy | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEUROBO PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Health Technology |
- Stock Market
- Insiders
- Matthew Bardin